Kanika Bahl is CEO and president of Evidence Action, an NGO that scales low-cost health interventions to improve the well-being of hundreds of millions of people in Africa and Asia. She is also on the board of TechnoServe and a trustee of Anthropic’s Long-Term Benefit Trust. Previously she served as managing director at Results for Development, or R4D, where she established and led the market dynamics practice. Prior to R4D, Kanika served as an executive vice president at the Clinton Health Access Initiative.